Applied Therapeutics GAAP EPS of -$0.15 beats by $0.03

• Applied Therapeutics press release (NASDAQ:APLT): Q1 GAAP EPS of -$0.15 beats by $0.03.
• Cash and cash equivalents and short-term investments totaled $50.8 million as of March 31, 2025, compared with $79.4 million at December 31, 2024.

More on Applied Therapeutics

• Seeking Alpha’s Quant Rating on Applied Therapeutics
• Historical earnings data for Applied Therapeutics
• Financial information for Applied Therapeutics